Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Lengauer

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2004
SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cellsManu Kohli, Jian Yu, Craig Seaman, et al.
Cancer Biology & Therapy|July 25, 2003
Analysis of anaphase figures in routine histologic sections distinguishes chromosomally unstable from chromosomally stable malignanciesElizabeth Montgomery, Robb E Wilentz, Pedram Argani, et al.
Nature|March 6, 2004
Inactivation of hCDC4 can cause chromosomal instabilityHarith Rajagopalan, Prasad V Jallepalli, Carlo Rago, et al.
Molecular & Cellular Oncology|September 26, 2018
Targeting kinases with precisionAlexandra K Gardino, Erica K Evans, Joseph L Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2002
The role of chromosomal instability in tumor initiationMartin A Nowak, Natalia L Komarova, Anirvan Sengupta, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2002
Digital karyotypingTian-Li Wang, Christine Maierhofer, Michael R Speicher, et al.
Cancer Research|February 28, 2002
Targeted inactivation of p53 in human cells does not result in aneuploidyFred Bunz, Christine Fauth, Michael R Speicher, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
PTEN-deficient cancers depend on PIK3CBSusan Wee, Dmitri Wiederschain, Sauveur-Michel Maira, et al.
Cancer Research|April 30, 2009
PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancersSusan Wee, Zainab Jagani, Kay Xiaoqin Xiang, et al.
Nature|May 26, 2006
Validating cancer drug targetsJohn D Benson, Ying-Nan P Chen, Susan A Cornell-Kennon, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|November 24, 2004
SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cellsManu Kohli, Jian Yu, Craig Seaman, et al.
Cancer Biology & Therapy|July 25, 2003
Analysis of anaphase figures in routine histologic sections distinguishes chromosomally unstable from chromosomally stable malignanciesElizabeth Montgomery, Robb E Wilentz, Pedram Argani, et al.
Nature|March 6, 2004
Inactivation of hCDC4 can cause chromosomal instabilityHarith Rajagopalan, Prasad V Jallepalli, Carlo Rago, et al.
Molecular & Cellular Oncology|September 26, 2018
Targeting kinases with precisionAlexandra K Gardino, Erica K Evans, Joseph L Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 2002
The role of chromosomal instability in tumor initiationMartin A Nowak, Natalia L Komarova, Anirvan Sengupta, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2002
Digital karyotypingTian-Li Wang, Christine Maierhofer, Michael R Speicher, et al.
Cancer Research|February 28, 2002
Targeted inactivation of p53 in human cells does not result in aneuploidyFred Bunz, Christine Fauth, Michael R Speicher, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
PTEN-deficient cancers depend on PIK3CBSusan Wee, Dmitri Wiederschain, Sauveur-Michel Maira, et al.
Cancer Research|April 30, 2009
PI3K pathway activation mediates resistance to MEK inhibitors in KRAS mutant cancersSusan Wee, Zainab Jagani, Kay Xiaoqin Xiang, et al.
Nature|May 26, 2006
Validating cancer drug targetsJohn D Benson, Ying-Nan P Chen, Susan A Cornell-Kennon, et al.
Pageof 8